About Anti-Aging Supplements & Therapeutics
The Anti-Aging Supplements & Therapeutics category is part of the Longevity & Human Enhancement market map, tracking 12 companies building in this segment. Senolytics, epigenetic reprogramming, exoskeletons, nootropics, and implantable devices pushing the boundaries of human lifespan and performance. Curated by Hartmann Capital's venture research team.
Companies in Anti-Aging Supplements & Therapeutics
- ChromaDex — Public, $50M
- DoNotAge
- ProHealth Longevity
- Renue By Science
- Tru Niagen — Subsidiary
- Life Extension
- Alive By Nature
- Longevity Labs
- Novos Labs — Seed, $2M
- Timeline Nutrition — Series B, $68M
- Juvenon
- Oxford Healthspan
Frequently Asked Questions
- What companies are in the Anti-Aging Supplements & Therapeutics category?
- The Anti-Aging Supplements & Therapeutics category includes 12 companies: ChromaDex, DoNotAge, ProHealth Longevity, Renue By Science, Tru Niagen, Life Extension, Alive By Nature, Longevity Labs, Novos Labs, Timeline Nutrition, Juvenon, Oxford Healthspan. This is part of the Longevity & Human Enhancement market map maintained by Hartmann Capital.
- How many Anti-Aging Supplements & Therapeutics startups are tracked?
- Hartmann Capital tracks 12 companies in the Anti-Aging Supplements & Therapeutics segment of the Longevity & Human Enhancement market map.
- What are the best funded Anti-Aging Supplements & Therapeutics companies?
- Top funded companies in Anti-Aging Supplements & Therapeutics include Timeline Nutrition ($68M), ChromaDex ($50M), Novos Labs ($2M). Browse the full list in the Longevity & Human Enhancement market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.